Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the Triojection® System in Patients With Symptomatic Lumbar Radiculopathy With or Without Back Pain Resultant From a Contained Herniated Lumbar Disc (L1-S1): A Pivotal, Randomized, Prospective, Multi-centered Study

NCT07856810 is registered in ClinicalTrials.gov with SpinaFX Medical Inc. as lead sponsor.

NCT NCT07856810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07856810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the Triojection® System in Patients With Symptomatic Lumbar Radiculopathy With or Without Back Pain Resultant From a Contained Herniated Lumbar Disc (L1-S1): A Pivotal, Randomized, Prospective, Multi-centered Study
Lead sponsor
SpinaFX Medical Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 15, 2027
Completion date
December 6, 2029
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contained herniated lumbar disc, lumbar disc herniation, lumbar radiculopathy